IGM BIOSCIENCES, INC. (IGMS) Social Stream



IGM BIOSCIENCES, INC. (IGMS): $22.48

0.49 (+2.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IGMS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

IGM BIOSCIENCES INC (IGMS) Price Targets From Analysts

Use the tables below to see what analysts covering IGM BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $119 $82 $99.25 $23.17 328.36%
2021-12-13 8 $126 $51 $86.625 $23.17 273.87%
2021-12-14 8 $126 $38 $78.875 $23.17 240.42%
2021-12-16 8 $126 $38 $74.125 $23.17 219.92%
2022-02-10 8 $126 $25 $72.5 $23.17 212.9%
2022-02-24 8 $90 $25 $64.375 $23.17 177.84%
2022-03-30 8 $90 $25 $63.625 $23.17 174.6%
2022-03-31 8 $74 $30 $56.857 $23.17 145.39%
2022-04-04 7 $74 $30 $55.5 $23.17 139.53%
2022-05-12 7 $74 $30 $53.875 $23.17 132.52%
2022-05-17 8 $74 $30 $53.75 $23.17 131.98%
2022-08-09 8 $74 $30 $51.875 $23.17 123.89%
2022-08-23 8 $61 $30 $47.25 $23.17 103.93%
2022-09-17 9 $61 $30 $45.777 $23.17 97.57%
2022-10-17 9 $61 $27 $43.9 $23.17 89.47%
2022-11-04 10 $61 $27.001 $43.8 $23.17 89.04%
2022-11-08 10 $61 $22 $39.6 $23.17 70.91%
2023-01-09 10 $58 $22 $39 $23.17 68.32%

The Trend in the Analyst Price Target


Over the past 32 months, IGMS's average price target has gone down $34.71.

Over the past 49 weeks, IGMS's average upside potential has been 164.36%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-31 8 126 25.000 72.500 17.70 309.6%
2022-09-17 9 61 30.000 45.777 20.85 119.55%
2022-11-04 10 61 27.001 43.800 16.50 165.45%
2022-11-08 10 61 22.000 39.600 17.20 130.23%
2023-01-09 10 58 22.000 39.000 18.31 113%

IGMS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 7 0 3 0 0 10

The Trend in the Broker Recommendations


IGMS's average broker recommendation rating worsened by 0.6 over the prior 34 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IGMS as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, IGM BIOSCIENCES INC's variance in analysts' estimates is lower than -1758.46% of them.
  • In terms of how IGM BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1807.36% of that group.
  • In terms of how IGM BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1655.02% of that group.
  • In the context of Pharmaceutical Products stocks, IGM BIOSCIENCES INC's number of analysts covering the stock is higher than 1531.45% of them.

In the Pharmaceutical Products industry, KRTX, BBIO, and MORF are the three stocks most similar to IGM BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding IGMS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.697 seconds.